Home Dialysis Systems Market Size, Share & Trends Analysis Report By Type (Hemodialysis, Peritoneal Dialysis), By Treatment (Acute Kidney Disease, Chronic Kidney Disease), By Region, And Segment Forecasts, 2022 - 2030

Report Overview

The global home dialysis systems market size was valued at USD 17.50 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 10.34% from 2022 to 2030. The growth of the market is attributed to technological advancements, risks associated with transplants, rising incidence of chronic kidney diseases, initiatives by the leading players to introduce advanced products and services, and shortage of organ donors are a few factors driving the demand for home dialysis systems, thereby propelling the market growth. For instance, in May 2021, relocating Outset Medical, Inc., a medical technology business that aims to minimize the complexity and cost of dialysis, has joined Health Home, an alliance of innovative healthcare companies aiming to radically redefine the way policymakers think about home healthcare. Through partnership in the healthcare sector, they want to persuade lawmakers to rethink the home as a center of care for clinical treatment, such as chronic disease management. As a result of such activities market is expected to grow in near future. 

In addition, the COVID-19 pandemic has led to a huge increase in dialysis demand around the world. For instance, according to Fresenius Medical Care, the number of dialysis patients in 2020 was about 346,553 as compared to 345, 425 in 2021. During the COVID-19 outbreak, home hemodialysis has gotten a lot of attention since it allows patients to do their dialysis at home in a safe atmosphere. According to Physidia, COVID contamination is 50% lower in-home dialysis patients than in in-center facilities, and numerous countries have implemented incentives to encourage more people to use home hemodialysis. For instance, in January 2021, ELSAN group and Physidia, signed a partnership agreement for the development of home hemodialysis in the private hospitals of the group in France, Therefore, the market is expected to grow as a result of such agreement. 

Through the COVID-19 pandemic, patients with kidney failure have benefited greatly from the remote patient management platform, who frequently have immunological dysfunction to do their dialysis at home, where they may remain safer by socially isolating themselves. For instance, in June 2021, the premium Analytics sharesource 1.0 module, the next generation of digital health for home-based peritoneal dialysis patients, has been launched by Baxter International Inc. Sharesource Analytics 1.0 is a clinical management resource included in the Sharesource remote patient management platform that provides healthcare providers with a comprehensive dashboard with trend data from their patients' home dialysis treatments. Baxter intends to roll out the product globally, beginning in the U.S, over the next year, and to charge a monthly fee. 

The increasing prevalence of chronic kidney disease is expected to boost the home dialysis products demand. For instance, as per the Centers for Disease Control and Prevention (CDC) 2020 report, ESKD, also known as end-stage renal disease, affects about 786,000 people in the U.S, with 29% requiring a kidney transplant and 71% requiring dialysis. According to the same source, at the end of 2018, 12.5% of all dialysis patients did their dialysis at home. Between 2008 and 2018, the number of patients undergoing home dialysis more than doubled. Thus this in turn is anticipated to spur the market growth in the near future.

U.S dominated the market in 2021. Due to various initiatives undertaken by organizations and governments, the demand for home care dialysis services is expected to increase over the forecast period. In 2021, America's Health Insurance Plans (AHIP) supports access to home dialysis as part of a kidney care campaign. Moreover, in July 2019, the administration's Advancing American Kidney Health Initiative has received full support from Baxter International Inc. By 2025, the Administration hopes to have increased the number of new end-stage renal disease (ESRD) patients receiving organ transplants and home dialysis to 80%. As a result of such initiatives, the market is expected to grow.

Type Insights:

Hemodialysis (HD) led the market and accounted for more than 86.41% share of the global revenue in 2021. Hemodialysis is the most common type of therapy for chronic diseases kidney failure. Various companies provide a wide range of hemodialysis products for home use. They include machines, dialyzers, bloodlines systems, hemodialysis solutions, and concentrates, water treatment systems as well as data processing and analysis systems. The segment is expected to grow due to various factors such as the rising incidence of acute kidney injury along with technological advancements. For instance, in March 2021, the next-generation Artificial Kidney 98 (AK 98) dialysis machine, which is meant to be an easy-to-use and portable device to give hemodialysis treatments, has been approved by the U.S FDA. Thus, this in turn is anticipated to boost the growth of the segment in near future.

Peritoneal dialysis (PD) is the second leading segment after hemodialysis. In the PD the peritoneum is used as a natural filter. Various companies offer systems and consumables for continuous peritoneal dialysis and automated peritoneal dialysis for use at home. According to AWAK Technologies, in recent years, studies have revealed that PD has a greater survival advantage than HD when utilized during dialysis beginning, especially during the first 1-2 years. In addition, PD offers significant advantages over HD: patient satisfaction is higher with PD systems, and PD costs are lower than HD expenditures. As a result of such studies, the segment is anticipated to grow in near future. However, the uptake of patients on PD is still much lower than HD- 11% globally and 21% of ESRD patients in Singapore.

Furthermore, the key market players are focusing on the launch of innovative products, growth strategies, and technological advancements which is likely to increase the demand for peritoneal dialysis products in near future. For instance, in February 2021, CloudCath Inc., a private medical device company focused on remote monitoring and real-time fluid analytics for infectious diseases, announced that the CloudCath System, a remote monitoring cloud-based platform for PD patients in the USD 74.5 billion ESRD market, has received FDA clearance in the U.S. In the next months, the business hopes to introduce the CloudCath System in a limited number of clinics across the U.S. 

Product Insights

In 2021, the service segment dominated the market with a share of over 55.44%. This is due to a rise in the number of dialysis service providers as well as an increase in the prevalence of ESRD. Furthermore, several major dialysis service providers are trying to extend their service offerings by opening or purchasing new dialysis centers throughout the world, which is projected to support segment growth. The industry is likely to grow even faster as a result of technological advances and initiatives done by various manufacturers. For instance, in February 2021, DaVita's home dialysis division now includes DaVita Care Connect, a secure telemedicine system. It was one of the company's numerous connected technologies targeted at enhancing treatment and outcomes for patients who prefer to treat themselves at home.

The consumables segment is expected to expand at the highest CAGR during the forecast period. Over the forecast period, governments are likely to make significant investments in order to improve patient safety, patient-centered care, and efficacy. Catheters composed of complex materials resistant to chemicals including peroxides, iodine, and alcohol are being developed by companies. This can assist extend the life of catheters and reduce the likelihood of them failing. In addition, the demand for antimicrobial-coated catheters is rising, reducing the risk of bloodstream infections. New dialyzer manufacturing technologies, such as better surface contact and cutoff membrane dialyzers for increased diffusion, are also helping the consumable segment grow. Bloodlines, concentrates, catheters, and other consumables have been categorized further in the consumables industry.

Treatment Insights

Chronic kidney disease led the market and accounted for more than 80.22% share of the global revenue in 2021. When a patient's kidneys no longer function effectively enough to avoid a deadly buildup of fluid and toxins in the body, ESRD is diagnosed. Chronic diseases such as high blood pressure or diabetes are the most common causes. According to an Outset Medical, at the end of 2019, there were around 810,000 ESRD patients in the U.S, with approximately 570,000 receiving dialysis and the rest requiring a kidney transplant. The total number of people with ESRD is almost 40% higher than it was ten years ago. Multiple pre-existing illnesses, as well as demographic variables such as diabetes, hypertension, obesity, and an aging population, are expected to push the prevalence of kidney failure to one million people by 2030, according to the same source. As a result, this market is expected to grow in near future.

The acute kidney disease segment is anticipated to witness the fastest growth over the forecast period. Acute kidney injury (AKI) is the loss of renal function for a short period. AKI is commonly caused by other medical illnesses or treatments, such as the loss of other organ functions, severe infection, medication toxicity, or surgical trauma. In order to survive, patients with AKI may require dialysis. According to data from the Centers for Medicare and Medicaid Services (CMS), the rate of beneficiaries having an AKI-related hospitalization increased between 2006 and 2016, with almost a third of these individuals being newly diagnosed with CKD within the next year. According to Outset Medical, about 450,000 admissions for AKI occur each year in the U.S.

Regional Insights

North America dominated the home dialysis systems market with the largest revenue share of over 38.40% in 2021. The significant investments by governments for the development of innovative medical devices, the presence of key participants, and the presence of a favorable reimbursement scenario are supplementing the growth of the market in the region. Due to the rising incidence of chronic kidney diseases (CKD), there is increasing demand for home dialysis.

Increasing healthcare spending, high disposable income, and government initiatives are a few other factors contributing to the market growth. For instance, in June 2021, Innovate Kidney Care is a new campaign sponsored by nine leading healthcare organizations to increase patient alternatives for receiving home dialysis support and training. The CVS Kidney Care, Anthem, Inc., American Society of Nephrology (ASN), Cricket Health, Intermountain Healthcare, Outset Medical, Inc., the National Kidney Foundation (NKF), and Strive Health are among the founding members. The mission of Innovate Kidney Care is to achieve the quadruple goal of better patient outcomes, improved health care practitioner experience, improved patient experience, and lower healthcare costs.

The Asia Pacific region is estimated to register the highest CAGR over the forecast period. Over the forecast period, the growing geriatric population, rising incidences of kidney failure, and the augmented development of advanced products are expected to support market growth. Furthermore, as per the IDF, in South East Asia, around 88 million adults are living with diabetes and the number is expected to increase to 153 million by 2045. Moreover, government initiatives, increasing healthcare spending, rising awareness campaigns regarding CKD, technologically enhanced products, and the presence of newly-established state-of-the-art healthcare facilities in the region are a few other factors contributing to market growth.

Key Players & Market Share Insights

Home dialysis system makers are speeding up their efforts to get their products licensed so that mass production may begin. In addition, the market players are adopting various strategies, such as acquisitions & mergers, partnership, product launches, and innovations such as the introduction of home dialysis systems products to strengthen their foothold in the market. For instance, in January 2019, Baxter International Inc. said that its Sharesource remote patient management platform has completed more than 5 million PD treatments at home throughout the world., which is expected to enhance the market growth in the near future. Some of the prominent players in the global home dialysis systems market include:

• B Fresenius Medical Care

• Cantel Medical.

• Baxter International Inc.

• Europlaz Technologies Ltd

• Quanta Dialysis Technologies

• Outset Medical

• AWAK Technologies

• DaVita.

Home Dialysis Systems Market Report Scope

Segments Covered in the Report

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest trends in each of the sub-segments from 2017 to 2030. For this study, Grand View Research has segmented the global home dialysis systems market report on the basis of type, product, treatment, and region:

• Type Outlook (Revenue, USD Million, 2017 - 2030)

  • Hemodialysis

    • Conventional

    • Short Daily Hemodialysis

    • Nocturnal Hemodialysis

  • Peritoneal Dialysis

    • Continuous Ambulatory Peritoneal Dialysis (CAPD)

    • Ambulatory Peritoneal Dialysis (APD)

• Product Outlook (Revenue, USD Million, 2017 - 2030)

  • Device

    • Machine

    • Dialyzers

    • Water Treatment System

    • Others

  • Consumables

    • Bloodlines

    • Concentrates

    • Catheters

    • Others

  • Service

• Treatment Outlook (Revenue, USD Million, 2017 - 2030)

  • Acute Kidney Disease

  • Chronic Kidney Disease

• Regional Outlook (Revenue, USD Million, 2017 - 2030)

  • North America

    • U.S.

    • Canada

  • Europe

    • U.K.

    • Germany

    • France

    • Italy

    • Spain

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

  • Latin America

    • Brazil

    • Mexico

    • Argentina

    • Colombia

  • Middle East and Africa (MEA)

    • South Africa

    • Saudi Arabia

    • UAE